Skip to main content
. 2020 Nov 25;124(4):721–727. doi: 10.1038/s41416-020-01141-8

Table 2.

Toxicity grade ≥ 3 according to treatment arm.

Adverse events
Grade ≥ 3
Arm A
(chemo)
Arm B
(chemo + cetux)
N = 72 N = 78
Leukopenia/neutropenia 14 (19%) 23 (29%)
Febrile neutropenia 0 (0%) 2 (3%)
Thrombopenia 2 (3%) 4 (5%)
Anaemia 4 (6%) 5 (6%)
Skin toxicity 0 (0%) 14 (18%)
Mucositis 2 (3%) 2 (3%)
Diarrhoea 5 (7%) 5 (6%)
Nausea/vomiting 2 (3%) 2 (3%)
Increased liver enzymes 2 (3%) 1 (1%)
Other gastrointestinal events 3 (4%) 6 (8%)
Fatigue/decreased performance status 4 (6%) 7 (9%)
Thromboembolic events 4 (6%) 4 (5%)
Syncope/falls 0 (0%) 2 (3%)
Arrhythmia 0 (0%) 2 (3%)
Other cardiovascular events 5 (7%) 6 (8%)
Polyneuropathy 3 (4%) 4 (5%)
Hypersensitivity 2 (3%) 2 (3%)
Pain 12 (17%) 13 (17%)
Other neurological events 2 (3%) 2 (3%)
Hypomagnesaemia 0 (0%) 4 (5%)
Renal events 2 (3%) 0 (0%)
Other lab events 3 (4%) 2 (3%)
Ascites/pleural effusion 3 (4%) 2 (3%)
Infections 3 (4%) 5 (6%)
Other events 4 (6%) 2 (3%)